1. Peter B, Karmin K. Clinical sports medicine 2002;2nd ed. Australia: McGraw-Hill. 439-440.
2. Peter B, Karmin K. Clinical sports medicine 2002;2nd ed. Australia: McGraw-Hill. 457.
4. Witvrouw E, Bellemans J, Lysens R, Danneels L, Cambier D. Intrinsic risk factors for the development of patellar tendinitis in an athletic population: a two-year prospective study. Am J Sports Med 2001;29:190-195.
5. Kannus P. Etiology and pathophysiology of chronic tendon disorders in sports. Scand J Med Sci Sports 1997;7:78-85.
7. Kannus P, Jozsa L, Natri A, Jarvinen M. Effects of training, immobilization and remobilization on tendons. Scand J Med Sci Sports 1997;7:67-71.
8. Lecomte J, Buyse H, Taymans J, Monti T. Treatment of tendinitis and bursitis: a comparison of nimesulide and naproxen sodium in a double-blind parallel trial. Eur J Rheumatol Inflamm 1994;14:29-32.
9. Dreiser RL, Ditisheim A, Charlot J, Lopez A. A double blind, placebo controlled study of niflumic acid gel in the treatment of acute tendinitis. Eur J Rheumatol Inflamm 1991;11:38-45.
10. Almekinders LC, Temple JD. Etiology, diagnosis, and treatment of tendonitis: an analysis of the literature. Med Sci Sports Exerc 1998;30:1183-1190.
11. Koen P, Roeland L. Patellar tendinopathy in athletes: current diagnosis and therapeutic recommendations. Sports Med 2005;35:71-87.
12. Peter B, Karmin K. Clinical sports medicine 2002;2nd ed. Australia: McGraw-Hill. 517-519.
13. Peter B, Karmin K. Clinical sports medicine 2002;2nd ed. Australia: McGraw-Hill. 391-392.